Flibanserin is a prescription medication approved for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in premenopausal women. HSDD is characterized by persistently low sexual desire that causes personal distress and is not better explained by medical conditions, medications, relationship issues, or other factors.
Unlike hormone-based therapies, Flibanserin works centrally in the brain by modulating neurotransmitters involved in sexual desire—specifically serotonin, dopamine, and norepinephrine. By rebalancing these pathways, Flibanserin may help restore sexual interest, motivation, and emotional connection.
At BHRT Delivered, Flibanserin is prescribed only after careful medical evaluation to ensure it is appropriate, safe, and aligned with a patient’s individual needs.
When used as prescribed and under medical supervision, Flibanserin may provide the following benefits:
Clinical studies show Flibanserin can increase sexual desire and reduce distress related to low libido in appropriate candidates.
By supporting sexual interest and responsiveness, Flibanserin may improve emotional and physical intimacy.
By influencing central neurotransmitters, some individuals report improved emotional well-being and confidence.
Flibanserin does not alter estrogen, progesterone, or testosterone levels, making it a distinct option for premenopausal women
Taken once daily at bedtime to support consistent neurotransmitter regulation.
Flibanserin may be appropriate for individuals who:
Are premenopausal women experiencing persistent low sexual desire
Experience distress, frustration, or relationship strain related to low libido
Have ruled out other contributing factors such as medical conditions, medications, or relationship issues
Prefer a clinically studied, non-hormonal treatment option
Want discreet, medically supervised care via telehealth
Flibanserin is not an instant solution and works gradually over time. Proper patient selection is essential for safe and effective treatment.
Flibanserin is FDA-approved specifically for:Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women, including:
Persistent lack of sexual desire causing personal distress
Reduced sexual motivation not attributable to another medical or psychological condition
Flibanserin is not approved for postmenopausal women, men, or for situational low libido, and it is not intended as a general aphrodisiac.
Before initiating prescription therapy, foundational strategies may help support sexual health:
Discussing intimacy concerns with a partner can help identify relational contributors.
Adequate, high-quality sleep is essential for libido, mood, and overall well-being.
Exercise improves circulation, energy levels, and confidence.
Chronic stress negatively affects sexual desire. Mindfulness, relaxation practices, or therapy may be beneficial.
Certain medications, hormonal imbalances, or mental health conditions may contribute to low libido and should be evaluated.
If these strategies are in place and distressing low desire persists, medical consultation may be appropriate.
At BHRT Delivered, Flibanserin therapy is approached with discretion, thoroughness, and personalized care.
A licensed provider reviews sexual health concerns, medical history, medications, and goals.
Potential contributing factors such as hormonal status, mental health, and relationship context are assessed.
If Flibanserin is appropriate, a tailored prescription plan is created with clear guidance on use and expectations.
Patients are monitored for effectiveness, side effects, and overall response, with adjustments made as needed.
Flibanserin is a clinically studied, non-hormonal medication designed to treat Hypoactive Sexual Desire Disorder in premenopausal women. By addressing neurochemical contributors to low libido, it offers a targeted approach to restoring desire, intimacy, and confidence when used appropriately.
Through secure telehealth care, BHRT Delivered provides confidential, evidence-based sexual health support focused on safety, education, and individualized treatment—without judgment or unnecessary barriers.
